Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2025

  1. Treatment Efficacy and Molecular Dynamics of Neoadjuvant Durvalumab and Olaparib in Resectable Urothelial Bladder Cancer: The NEODURVARIB Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 31, Núm. 9, pp. 1644-1656

2023

  1. Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution

    Frontiers in Immunology, Vol. 14

2007

  1. Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

    Human Mutation, Vol. 28, Núm. 6, pp. 613-621

2005

  1. Brief report: Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 4, pp. 2127-2130

2002

  1. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma

    European Journal of Human Genetics, Vol. 10, Núm. 8, pp. 457-461